NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

Abstract Background We tested the hypothesis that, after initial improvement with intravenous ketamine in patients with bipolar disorder (BD) with severe depression and acute suicidal thinking or behavior, a fixed-dose combination of oral D-cycloserine (DCS) and lurasidone (NRX-101) can maintain imp...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrew Nierenberg, Philip Lavin, Daniel C. Javitt, Richard Shelton, Michael T. Sapko, Sanjay Mathew, Robert E. Besthof, Jonathan C. Javitt
Format:	Artigo
Idioma:	Inglês
Publicat:	SpringerOpen 2023-08-01
Col·lecció:	International Journal of Bipolar Disorders
Matèries:	Bipolar disorder Depression Suicidal ideation Ketamine Lurasidone Hydrochloride Cycloserine
Accés en línia:	https://doi.org/10.1186/s40345-023-00308-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!